๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

RhoA: A therapeutic target for chronic myeloid leukemia

โœ Scribed by Poonam R Molli, Madhura B Pradhan, Suresh H Advani, Nishigandha R Naik


Book ID
119901822
Publisher
BioMed Central
Year
2012
Tongue
English
Weight
844 KB
Volume
11
Category
Article
ISSN
1476-4598

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Targeted therapy of chronic myeloid leuk
โœ Con Sullivan; Cong Peng; Yaoyu Chen; Dongguang Li; Shaoguang Li ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 297 KB
Targeting Chronic Myeloid Leukemia Stem
โœ G. Vignir Helgason; Graham A. R. Young; Tessa L. Holyoake ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Current Science Inc. ๐ŸŒ English โš– 221 KB
Therapeutic targets in chronic myeloid l
โœ Nicholas B. Heaney; Tessa L. Holyoake ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 162 KB

## Abstract Chronic myeloid leukaemia (CML) is a clonal disorder of the haemopoietic stem cell arising as a consequence of the formation of the __bcrโ€abl__ oncogene. The particular molecular basis of this condition has enabled the development of therapies that selectively target diseased cells. The

Chronic myeloid leukemia as an immunolog
โœ Lim, Seah H.; Coleman, Sharon ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 72 KB

Various clinical observations have implicated T cells in the control of chronic myeloid leukemia (CML). These observations have in recent years been supported by laboratory results indicating the presence of CML-specific T cells in the lymphocyte repertoire of both normal healthy individuals and dis